Volume 8, Issue 2, April 2018
Main Menu
FORMULATION AND CHARACTERIZATION OF PALIPERIDONE LOADED MUCOADHESIVE MICROEMULSION FOR INTRANASAL DELIVERY
Author(s): Tulasi Ashwin Kumar and Anil Goud Kandhula
Abstract: Paliperidone (PPD) is used for the treatment and management of schizophrenia. The present study demonstrates the potential of mucoadhesive microemulsion of PPD for nasal delivery. PPD-MME was prepared by water titration method, prepared formulations were subjected to physicochemical characterization, and evaluated for size, zeta potential, PDI, pH and stability studies. The microemulsion, containing 5% oleic acid (oil Phase), 40% surfactant mixture of Tween 80(surfactant): Transcutol HP (cosurfactant) (2:1) and 55% aqueous phase, that displayed globule size of 94.8±0.34nm, a PDI of 0.25±0.22 and zeta potential was 14.5±0.4 mV, chitosan was selected for the incorporation of polyelectrolytic polymer as the mucoadhesive component. The mucoadhesive microemulsion formulation of Paliperidone that contains 0.5 % by weight of chitosan.
PAGES: 844-849 | 167 VIEWS 345 DOWNLOADS
How To Cite this Article:
Tulasi Ashwin Kumar and Anil Goud Kandhula. FORMULATION AND CHARACTERIZATION OF PALIPERIDONE LOADED MUCOADHESIVE MICROEMULSION FOR INTRANASAL DELIVERY. 2018; 8(2): 844-849.
